| Bioactivity | Guanosine triphosphate-13C10,15N5 (tetraammonium) is the 13C and 15N labeled Guanosine triphosphate tetraammonium[1]. Guanosine triphosphate is a native nucleotide. The derivatives of GTP may be used as specific inhibitors against COVID-19[2]. |
| Invitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| Name | Guanosine triphosphate-13C10,15N5 (tetraammonium) |
| Formula | 13C10H28N415N5O14P3 |
| Molar Mass | 606.20 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Guanosine triphosphate-13C10,15N5 (tetraammonium)
CAS: F: 13C10H28N415N5O14P3 W: 606.20
Guanosine triphosphate-13C10,15N5 (tetraammonium) is the 13C and 15N labeled Guanosine triphosphate tetraammonium. Guano
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.